Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
May 14
Recall Expansion of Durisan Non-Alcohol Hand Sanitizer
Drugs
May 14
BUBS Naturals of Encinitas, CA Is Voluntarily Recalling Certain Lots of Its MCT Oil Powder Product Due to Undeclared Milk
Food & Beverages
May 12
Hi Tech Pharmaceuticals Issues Voluntary Recall on Lipodrene w/25mg Ephedra Extract Dietary Supplement Due to the Presence of 1,4-dimethylamylamine (DMAA)
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Advancing FDA’s Mission by Targeting Key Areas for Regulatory Science Investment and Innovation
The FARS Report communicates the importance and impact of the FDA’s regulatory science research activities and identifies cross-cutting areas.
FDA Stresses Critical Importance of Safe Disposal of Medications Ahead of National Prescription Drug Take Back Day
For many years, the U.S. Food and Drug Administration has strongly supported work to expand the availability of drug take back programs.
Advancing the Development of Safe and Effective Regenerative Medicine Products
Innovative medical products such as cellular-derived therapies, including stem cell-based products, offer the potential to treat or even cure diseases.
Recently Published Guidances
May 17
Manufacturing, Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers
Biologics, Drugs
May 17
COVID-19: Master Protocols Evaluating Drugs and Biological Products for Treatment or Prevention
Biologics, Drugs
May 11
Q3D(R2) – Guideline for Elemental Impurities
Biologics, Drugs